Greney H, Molines A, Bousquet P, Dontenwill M
CNRS URA 589, Faculté de Médecine, Université Louis Pasteur, Strasbourg, France.
Eur J Pharmacol. 1994 Dec 27;271(2-3):533-6. doi: 10.1016/0014-2999(94)90815-x.
The affinity of AMPI (2-[3-aminophenoxy]methyl imidazoline) for [3H]clonidine and [3H]idazoxan imidazoline binding sites was determined in various rabbit and human tissues. Although cirazoline showed a high affinity (nM range) in all the tested tissues, its derivative, AMPI, had a high affinity (nM range) in rabbit brain and kidney but a low affinity (microM range) in the human brain. These differences in affinities were very similar to those obtained with amiloride. The same results were obtained when considering [3H]clonidine or [3H]idazoxan specific imidazoline binding sites.
在各种兔和人组织中测定了AMPI(2-[3-氨基苯氧基]甲基咪唑啉)对[3H]可乐定和[3H]咪唑克生咪唑啉结合位点的亲和力。尽管西拉唑啉在所有测试组织中都表现出高亲和力(纳摩尔范围),但其衍生物AMPI在兔脑和肾中具有高亲和力(纳摩尔范围),而在人脑中具有低亲和力(微摩尔范围)。这些亲和力的差异与用阿米洛利得到的差异非常相似。考虑[3H]可乐定或[3H]咪唑克生特异性咪唑啉结合位点时,得到了相同的结果。